Martingale Asset Management L P Ngm Biopharmaceuticals Inc Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$15.06 - $30.03 $200,448 - $399,699	-13,310 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$24.99 - $31.93 $4,998 - $6,386	-200 Reduced 1.48%	13,310 $386,000
Q4 2020 Feb 10, 2021	SELL	$16.21 - $31.44 $145,841 - $282,865	-8,997 Reduced 39.97%	13,510 $409,000
Q3 2020 Nov 12, 2020	BUY	$15.59 - $19.97 $350,884 - $449,464	22,507 New	22,507 $358,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.